Two charged with importing misbranded erectile dysfunction drug into Rhode Island

Webp 943lv9otumxoc4vzhe7pu04ipy9p
Sara Miron Bloom Acting United States Attorney for the District of Rhode Island | News From The States

Two charged with importing misbranded erectile dysfunction drug into Rhode Island

Two individuals are facing federal charges in Providence related to the importation and distribution of a misbranded drug from India. According to Acting United States Attorney Sara Miron Bloom, the ongoing investigation centers on the introduction of pills containing sildenafil citrate into Rhode Island and other parts of the Northeast without approval from the Food and Drug Administration (FDA).

Court documents state that Jitender Behl, 74, of East Greenwich, Rhode Island, imported hundreds of thousands of pills containing sildenafil citrate. Sildenafil is an active ingredient in prescription medications approved by the FDA for treating erectile dysfunction.

Behl is accused of repackaging these pills as an all-natural dietary supplement under the brand name “JMY,” which stands for “Just Me & You.” The pills were then distributed to Noor Inc., a wholesale distributor based in Providence. Law enforcement has seized over 130,000 imported sildenafil pills and tablets, more than 650 grams of sildenafil soft gel capsules, and around 21,700 empty Mylar bags allegedly used for packaging.

According to court records, JMY’s website listed Noor Inc. as its sole U.S. wholesale distributor. Noor Inc. supplied retail outlets in Rhode Island and Massachusetts with JMY products. Undercover agents from the FDA reportedly purchased packages of “JMY” at these retail locations. The product’s ingredient list did not mention sildenafil but instead included items such as “White Willow Bark” and “Korean Ginseng.”

The FDA warns that sildenafil can be especially dangerous for people taking heart medications containing nitrates because it may cause blood pressure to drop to unsafe levels.

Behl was arrested on charges including receipt in interstate commerce of misbranded drugs and introducing misbranded drugs. He appeared before a U.S. Magistrate Judge and was released on unsecured bond.

Mahr Ahmed, 58, of Attleboro, Massachusetts, owner of Noor Inc., has been charged by information filed on July 23, 2025, with introducing misbranded drugs. Court documents indicate that Ahmed has agreed to plead guilty.

“A federal criminal complaint is merely an accusation. A defendant is presumed innocent unless and until proven guilty.”

Assistant U.S. Attorney Dulce Donovan is prosecuting the case.

The investigation involved several agencies: United States Food and Drug Administration Office of Criminal Investigations Rhode Island Task Force, Warwick Police Department, Homeland Security Investigations, United States Postal Inspection Service, and United States Customs and Border Protection.